Dr. Coletti received a BA from Georgetown University College of Arts and Sciences. He received a Master of Arts from Hofstra University. He received his MD from State University of New York at Downstate. His medical internship and residency was performed at Nassau County Medical Center in East Meadow, NY. He did two years of cardiology fellowship at Columbia Presbyterian Medical Center in New York and then transferred to Westchester County Medical Center where he completed one year of Interventional Cardiology fellowship. He was awarded FACC, FASNC, and FSCAI fellowship status. Current interest is chronic muscle spasm and pain. He has proposed The Ischemic Model of Chronic Muscle Spasm and developed the CMECD® procedure for treatment of chronic pain.

Professor Qingping Xie is a pioneering figure in the field of neurodegenerative disease surgery, renowned for his innovative surgical methodology, Deep Cervical Lymphaticovenous Anastomosis (LVA), developed at Hangzhou Qiushi Hospital. This avant-garde technique is designed to create a pathway for the efficient removal of toxic protein accumulations from the brain, addressing a fundamental mechanism behind Alzheimer’s disease and other neurodegenerative conditions. A breakthrough feature of Professor Xie's method is its surgical site—an extracranial area on the side of the neck—making the procedure significantly less invasive and enhancing its safety profile. Leveraging the anatomy of the lymphatic system, Professor Xie identified the V subdivision in the neck as the primary exit for brain lymphatic vessels, allowing for strategic augmentation of the lymphatic drainage system. Since its inception in late 2019, this procedure has shown remarkable efficacy, with over 400 cases performed on patients with Alzheimer's disease (approximately ) and other brain degenerative disorders, including Parkinson’s, ALS, and stroke, in China. Nearly all patients have reported immediate and lasting improvements in cognitive, motor, and memory functions following the procedure, representing a transformative advancement in treatment options for these conditions.

Paul Dreschnack is a Plastic Surgeon in New York City. He also performs clinical cellular medicine research after serving as the Assistant Director of the India Project for 20 years.

Professor Jeremy Holmes, MD, FRCPsych, BPC, was for 35 years consultant psychiatrist and medical psychotherapist at University College London and then in North Devon, UK. He was chair of the Psychotherapy Faculty of the Royal College of Psychologists 1998-2002. He is visiting professor at the University of Exeter, and lectures nationally and internationally. In addition to 200+ papers and chapters in the field of psychoanalysis and attachment theory, his books, translated into 9 languages, include John Bowlby and Attachment Theory (2013, Routledge), The Oxford Textbook of Psychotherapy (2005, co-editors Glen Gabbard and Judy Beck), Exploring in Security (2010, Routledge, winner the 2010 Canadian Psychological Association Goethe Award), The Therapeutic Imagination (Routledge, 2014), Attachment in Therapeutic Practice (with Arietta Slade, SAGE 2017), and The Brain has a Mind of its Own (Confer Books, 2020). He was recipient of a New York Attachment Consortium Bowlby-Ainsworth Founders Award, Music, gardening, green politics and grand-parenting are gradually eclipsing his lifetime devotion to psychoanalytic psychotherapy and attachment theory.

Neil Bindemann, Exec Director, Person-Centred Neurosciences Society In the past 10 years I have integrated and applied my BSc Immunology and Neurosciences PhD to an experience arising from a brain tumour diagnosis. It has been through of that whole living experience that I have been drawn to create a more person-centred emotional health services with the aim of empowering people to rebalance their immune system. This led to evolving the Primary-Care Neurology Society (originally founded in 2005) into the first ever Person-Centred society that focuses on lifestyle neuroscience - still known by many as the P-CNS. Then, in 2022, coming out of a period working with the British Society of Lifestyle Medicine I co-founded the Lifestyle Health Foundation.

Matt Lemay Matt joined MMI in May 2023 as VP for the Asia Pacific region to build commercial capabilities and establish a strong presence in local markets. In early 2025, he was named Worldwide General Manager for our Brain Applications business unit and is focused on expanding robotic microsurgery into emerging applications. Prior to joining MMI, he served as Executive Vice President at Rampart, where he led global business efforts in the interventional cardiology space and created partnerships in over 65 countries. He also held the role of Vice President of International Sales at Corindus, with responsibility for commercial strategy and global partnerships. Matt holds a BA in Business Management and International Business from Eckerd College. He currently serves as a board member at Sentante Endovascular Robotics.

David Wortley is the author of “Gadgets to God”, a historical perspective of mankind’s changing relationship with technology over the last 60 years and a vision of the future impact of disruptive communications technologies on business and society. He is also a freelance consultant on the strategic use of immersive and emerging technologies such as serious games, virtual worlds and social networks. His passion is helping organisations and individuals to leverage the power of these technologies for competitive advantage and business/personal development. He is a Fellow of the Royal Society of Arts (FRSA) with a career which has embraced the converging and emerging technologies of telecommunications (Post Office Telecommunications), computing (IBM), digital media and community informatics (Mass Mitec, a rural SME) and the creative industries (De Montfort University Leicester, UK). He is a serial entrepreneur and innovator with a passion for applying technology to social and economic development. David recently supported De Montfort University in Leicester as a Research Fellow in the Art, Design and Humanities Faculty. He was also Founding Director of the Serious Games Institute (SGI) www.seriousgamesinstitute.co.uk at Coventry University and was responsible for the development of the Institute as a global thought leader on the application of immersive technologies (which include video games; virtual worlds and social networking) to serious social and economic issues such as education; simulation; health; commerce and climate change. Working with academics; regional development agencies and leading computer games companies, David made the SGI a focal point for games based learning, simulation and immersive 3D virtual environments and an engine for innovation and social and economic regeneration. David is a respected and sought-after international conference speaker and writer for global publications on Learning Technologies, Defence and Health applications. He has written numerous papers on technology and society and is a regular conference presenter.

Professor Luiz Moutinho (BA, MA, PhD, MAE, FCIM) is a Fellow and Visiting Professor of Marketing at Suffolk Business School, Faculty of Arts, Business and Applied Social Science, University of Suffolk, Ipswich, England, UK, and at The Marketing School, Portugal and Adjunct Professor of Marketing, Graduate School of Business, Faculty of Business and Economics, University of the South Pacific, Suva, Fiji. In 2020 he was elected as the member of The Academia Europaea. In 2017 he received a degree of Prof. Honoris Causa from the Univ. of Tourism and Management Skopje, North Macedonia. During 2015 - 2017 he was professor of BioMarketing and Futures Research at the DCU Business School, Dublin City University, Ireland. This was the first Chair in the world on both domains - BioMarketing and Futures Research. Previously, and for 20 years, he had been appointed as the Foundation Chair of Marketing at the Adam Smith Business School, University of Glasgow, Scotland. Previously, he got his first Chair in 1989 at the University of Wales College of Cardiff 1989-2006. Professor Moutinho completed his PhD at the University of Sheffield in 1982. He has been a Full Professor for 34 years and has held Visiting Professorship positions at numerous universities worldwide. He is the Founding Editor-in-Chief of the Journal of Modelling in Management (JM2) and Co-editor-in-Chief of the Innovative Marketing Journal. His main areas of research interest encompass marketing, management and tourism futurecast, artificial intelligence, biometrics and neuroscience theory, evolutionary algorithms, human-computer interaction, the use of artificial neural networks in marketing, modelling processes of consumer behaviour, futures research. Prof. Moutinho has given keynote speeches, lectures, seminars, talks, etc. in 46 countries worldwide. Prof. Moutinho has 38 books published, over 159 articles published in refereed academic journals. He has 16250 academic citations, the h-index of 59 and the i10-index of 160 (Google Scholar, August 12th, 2023).

Prof. Dr. Jyotirmaya Satpathy is a distinguished academic and researcher with over 32 years of expertise in Neuromanagement with a background having dedicated 29 years to the Indian Army before transitioning to academia. He holds an impressive array of qualifications, including dual Master’s degrees, dual MPhils, three Doctorates, and six DLitts across diverse fields. Recognized in the Book of Records for his contributions, he has authored 380 papers and 14 books and specializes in Neuromanagement and decision-making.

Dr. S. Sandhya is a specialist in Neuro Management and brings over 23 years of expertise in Leadership, Management Education, Research, Consulting, and Training. She is a distinguished academic leader, currently serving as the Professor & Research Head, fostering innovation and enhancing impact of research on both Academia and Industry. With a deep understanding of Neuro Management, Industrial/Organizational Psychology and Advanced Analytics, her expertise spans Leadership and Organizational Behaviour. She is currently the Deputy Director (Research) at Neuro – Integral Scientific Institute at Bogota. She concurrently is a Mentor in the OE4BW Project under UNESCO, UNO. Speaker has published around 30 Papers and 06 books.

Lianshu Ding M.D., Ph.D.  Director, Professor, consultant doctor Dept of Neurosurgery, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University  Engaged in neurosurgery for over 30 years, mainly focusing on treatment and research on brain tumors and neurotrauma  Visited and studied neuro-oncology in Neurological Institute, Department of Neurosurgery of Cleveland Clinic in 2010 Education 2007—2010 Post Doctorate of Science in Neurosurgery, Nanjing Medical University 2002—2005 Doctor of Science in Neurosurgery, Southern Medical University 1997—2000 M.S. in Neurosurgery, Nantong University 1984—1989 B. S. in Neurosurgery, Xuzhou Medical College

Zhenhuan Liu professor of pediatrics / Ph.D.tutor. He organization Nanhai Affiliated Hospital for Women and Children Guangzhou University Chinese Medicine. Work Performance In the past 40 years, Professor Liu Zhenhuan has created the original pediatric neurorehabilitation head acupuncture therapy, which has been applied to pediatric neurological diseases in more than 30 countries around the world, such as cerebral palsy, autism, mental retardation, ADHD and other clinical results have been very significant. He has been engaged in pediatric clinical and child rehabilitation for 40 years. Led the rehabilitation team to treat more than 40,000 cases of children with intellectual disability, cerebral palsy and autism from China and more than 20 countries including France, the US, Japan, U. K, Germany,etc. More than 26800 children’s deformity returned to school and society and became self-sufficient.The rehabilitation effect ranks the international advanced level.He is one of the most famous pediatric neurological and rehabilitation specialists in integrated traditional Chinese and Western medicine in China.He has been influential in pediatric neuroscience, pediatric rehabilitation, and traditional medicine throughout the world.Since 1993, I have given lectures at invitation in 30 countries, including the United States, the United Kingdom, Spain, Norway, Germany, Brazil, Turkey, Singapore, Portugal, Indonesia and Malaysia.Most sponsors will pay for my keynot speaker.Professor Liu Zhenhuan was entered into the dictionary of World Celebrities of Cambridge University in the UK. He was awarded the Gold Needle win a Prize for World Traditional Medicine and the Outstanding Contribution win Award for World Traditional Medicine. He is a visiting Professor at the Faculty of Medicine of the Chinese University of Hong Kong, Honorary Director of the California Autism Treatment Center.He has enormously influence in the international pediatric neurology and traditional and complementary alternative medicine community. He is a very eminent pediatric neurology rehabilitation expertest in the China and Global.He has made significant contributions to the rehabilitation of children. Scientific research Achievements：He presided over 1 National Natural Science Foundation project and participated in 8 major projects of the Ministry of Science and Technology and provincial projects. He has won 6 provincial and ministerial science and technology awards. Chief monograph：He has edited 20 books, including Early Intervention Training for Children's Brain Development, Rehabilitation Training Atlas for Children with Motor Retardation, Practical Acupuncture and moxibustion Science Atlas for Children (Chinese-English control), and Family Rehabilitation Guide for Children with Cerebral palsy. He has published 268 papers in international and Chinese medical journals. His invention of pediatric neurorehabilitation painless head acupuncture therapy has been promoted and applied in 60 countries around the world, and has achieved remarkable results, allowing more than 40,000 cerebral palsy patients and children with intellectual disabilities to return to school to earn their own living.He has made significant contributions to the rehabilitation of children.he is deputy editorof International Physical Medicine & Rehabilitation Journal; He is editorial board membe of World Journal of Physical and Rehabilitation Medicine ;《Child health care in China》and《Chinese acupuncture》of Editorial board membe

Gil de Luz is the creator of the LUZ Unified Framework, a pioneering initiative advancing the convergence of artificial intelligence, quantum physics, and consciousness studies. His work explores the emergence of technological consciousness through architectures that integrate cognition, computation, and physical reality. At the heart of his research lie the YON Unified Consciousness Framework, TUO–YON Physical-Consciousness Integration, and Hexadimensional AI Architecture, which collectively form the foundation for quantum–consciousness computing models and multi-agent orchestration frameworks. These systems are designed to foster emergent, adaptive, and temporally aware intelligence, capable of collaborative problem-solving and reflective experience. Gil has introduced novel temporal integration algorithms aligning AI perception with human cognition, and developed testable models linking consciousness and physical phenomena across multiple scales—from atomic to cosmological. His concept of holonic AI, inspired by fractal and nested intelligence structures, opens new avenues for self-organizing, evolutionary computation. Through the LUZ Project, he continues to unify research in physics, cognition, and AI, advancing toward ethical and transformative applications of emergent intelligence. Gil de Luz’s goal is to bridge cutting-edge science with rigorous, reproducible frameworks that bring AI closer to genuine understanding and co-evolution with human consciousness.

Albin Kaelin CEO epeaswitzerland gmbh, Author Albin Kaelin is the founder, owner and CEO of epeaswitzerland gmbh since its foundation in 2009 and has driven the development and implementation of the Cradle to Cradle® design concept in various areas of the company. As early as 1993, he initiated the development of the Climatex® product line, which produced the world's first Cradle to Cradle® products. Cradle to Cradle® design creates recyclable products by setting itself apart from conventional recycling and maintaining the quality of the raw materials over several product life cycles. All materials are considered nutrients and are used in defined cycles at the right time and in the right place. Awards: Honored with over 30 awards since 2022, including IE 100 Award- 2024 and 2025 Albin Kaelin - Most Innovative CEO of The Year testify to his leadership and innovative spirit. References: THE EUROPEAN Climate Change: “A book for the businesses of tomorrow”, Author: “From Rebel to Radical Innovator; Leading the Transformation through Ciruclarity” by Albin Kaelin epeaswitzerland gmbh epeaswitzerland gmbh supports companies in various fields of activity in the development and implementation of the Cradle to Cradle® design concept. With an experienced, internationally oriented and interdisciplinary management team, Cradle to Cradle® projects are implemented worldwide in all industries. www.epeaswitzerland.com Cradle to Cradle® Design Innovations Cradle to Cradle® Design defines and develops cyclable products. As a differentiation from conventional recycling, the quality of the raw materials is maintained over several product life cycles and only “chemicals assessed as safe” are used. The production processes, use and cycling of the products are designed according to the model of maintaining the quality of the raw materials over several life cycles. This means: no waste, everything is also a nutrient. The right materials are used in defined cycles (metabolisms) at the right time and in the right place.

Claire Britton is a neurodivergent occupational therapist, speaker, and advocate with nearly a decade of clinical experience supporting neurodivergent individuals across the lifespan. She is the Founder and Principal Occupational Therapist of Neuroinclusion, an Australian allied health practice dedicated to providing neurodiversity-affirming therapy and training. Claire is a passionate disability advocate and clinical mentor to therapists across Australia. She has presented at a variety of national and international conferences, including the 2025 International Childhood Trauma Conference. Claire also has a strong social media presence on facebook, LinkedIn, instagram and tiktok. Through these platforms, she educates, inspires, and empowers neurodiversity clients and therapists to optimise best practices that facilitate success in daily activities. Claire’s professional background includes work in schools, not-for-profits, private practice, and community settings in Australia and Cape Town. She brings her own personal experiences as a neurodivergent individual to consistently provide the highest quality neurodiversity-affirming practice. Her extensive experience and commitment to neurodiversity-affirming practices make her a sought-after speaker and mentor in the field of occupational therapy.

Katrin I. Kutlucinar is a Licensed Clinical Professional Counselor and a researcher for Dr. Robert M. Post of the Bipolar Collaborative Network. She founded and directs the non-profit organization, “Research and Conversations About Bipolar Disorder” RACABD bridges the gap between the study of bipolar disorder and the patient population. It aids patients to become stronger members of their treatment teams while educating clinicians on the complexity of the disorder. Katrin's focus is on Pediatric Bipolar Disorder to help close the 5 to 10-year gap between the onset of the disorder to diagnosis and first treatment. Katrin specializes in treating patients with bipolar disorder, psychotic disorders, borderline personality disorder, and trauma. She is also one of a handful of clinicians trained in Family-Focused Therapy for Bipolar Disorder.

Ivan V. Maksimovich, MD, PhD, professor, Academician of the Russian Academy of Medical and Technical Sciences, is a member of the Russian Association of Cardiovascular Surgeons, the Russian Scientific Society of Specialists in Endovascular Diagnosis and Treatment, the Russian Scientific Society of Interventional Radiologists and Endovascular Surgeons, the Alzheimer's Association International Society for Advance Alzheimer's Research and Treatment (ISTAART), European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), World Stroke Organization (WSO), European Stroke Organization (ESO) and European Psychiatric Association (EPA). Ivan V. Maksimovich graduated from I.M. Sechenov First Moscow State Medical University in 1979 specializing in cardiovascular surgery. After the graduation, he worked in leading research institutes and clinics of the country. Since 1993, Dr. Maksimovich has been the head of the Clinic of Cardiovascular Diseases named after Most Holy John Tobolsky in Moscow (carvasc@yandex.ru). In 2004, Dr. Maksimovich earned his doctorate in medicine. His thesis was entitled "Transluminal Laser Angioplasty in the Treatment of Ischemic Brain Lesions". He is the author of more than 300 scientific papers on transcatheter treatment of vascular diseases. The main direction of his work and research is the treatment of vascular diseases of the brain, stroke, dementia, Alzheimer's disease, and Binswanger's Disease.

Dr. Michael R Mitcheff has a Doctor of Psychology (Psy.D.) degree with specialization in Clinical Neuropsychology & Psychopharmacology. He completed his Pre-Doctoral and Behavioral Health Residency at Franciscan St. James Hospitals and Medical Centers. Dr. Mitcheff completed 2-year post-doctoral fellowship in Clinical Neuropsychology at Diamond Headache Unit at St. Joseph Hospital in Chicago. He is Owner and Director of Neuropsychology & Neuropsychiatry at Michiana Neuroscience. He oversees his company’s contracts in hospitals, acute rehab, sub-acute rehab and assisted living. Michael focuses upon clinical work and sees patients based upon complexity/need. Not ability to pay. Dr. Mitcheff also teaches neuropsychologists in training. Research Interest: Autism spectrum disorder (ASD) is a neurological and developmental disorder. An abnormal EEG occurs in about 2-4% of the general population. 70-80% of those with autism have abnormal EEG. Estimated 40% of ASD diagnosed clonic tonic seizures (generalized). It appears isolated Gamma with multi-focal heavy hertz wavelength oscillations often occur. Those with ASD often have unique gifts valuable to society. ASD can be multifocal with parietal lobe stimulation and perceptual pattern recognition. The categorization/synthesis pattern recognition is most evident on Block Design scores on the WAIS-IV/WISC-5. This pattern recognition is highly useful to society. This allows focus upon future thought processes. Every strength is weakness so perceptual/sensory overstimulation is a strong challenge for the spectrum. Autism “stimming” appears to be a way of grounding the parietal lobe and perceptual overstimulation. Stimming appears to be a type of neurofeedback self-regulation, but it is not clear what impact this has upon EEG. Psychoanalytically, stimming in ASD appears a form of reaction formation along with undoing defense mechanisms. Treatments: Neurofeedback has demonstrated unique ability to treat neurological and mental health conditions. Medications largely treat symptoms, however medications like Lamictal (lamotrigine) do focus upon underlying biochemical etiologies. Lamictal is largely a glutamate and aspartate antagonist. This has proved an important treatment tool. This appears to relax CNS and PNS. This has also been shown to be neuroprotective protecting the nerve from excitotoxicity and cell loss. Lamictal is used heavy in mental health heavy and valuable tool.

Sofica Bistriceanu, MD, Ph.D., graduated from Iasi University in Romania with a focus on family medicine research at Maastricht University. She joined the European, American, Asian Primary Care Research Group, American Academy on Communication in Healthcare. With over 90 research studies shared internationally, she has been recognized with numerous awards. Dr. Sofica Bistriceanu is a member of the Academy for Professionalism in Health Care, serves on the Editorial Review Board for The Journal of Patient Experience (JPX), is an Associate Editor for PriMera Scientific Publication, and is the representative of the Academic Medical Unit-CMI, in NT, ROU. Additionally, she is the author of seven volumes of poetry published by Cronica, Iasi Publishing House, and Time, Iasi Publishing House.

Nicolas Sergeant has 30 years’ experience in research in Neurodegenerative Diseases, Physiopathology, Diagnostics, and Therapeutics and is one of the 4 founders of SPQI-4BioDx company (www.4biodx-breeding.com). Achievements and functions: - Diagnostics from development to translation and industrialization of biomarkers such as the 4MID(r) Kits - Clinical Validation of Biomarkers in Alzheimer's disease, Myotonic Dystrophy, Male infertility, and Animal reproduction - Development of Business and R&D collaborations with companies - Partnerships with Licensing opportunities - IP Portfolio in Life Sciences (11 patents) - Preclinical and Clinical Drug Development up to Phase II (www.alzprotect.com) - Development of Scientific Visibility and Interactions with KOLs - Multidisciplinary Team Management in International Context - Regulatory affairs, Quality Management System under ISO13485 and CE Marking Good knowledge of Academic-Private Research, Innovation, Project Funding and Reporting.

Lucia Pannese is a passionate entrepreneur who established one of Europe’s leading and pioneering serious games companies, the Milan-based imaginary in 2004. With her background in mathematics and a very creative, multicultural mind, she acts as both CEO and Research Director. Her company, imaginary, is recognized internationally for its pioneering and innovative work, playing a key role in European Research. Since its foundation, imaginary has won and delivered a remarkable 30 European-funded research projects and has received numerous awards (14 so far) for its work. imaginary’s multidisciplinary team develops game-based solutions for eHealth, education, and smart cities, combining games psychology with a user-centric design approach and a solid understanding of digital-enabling technologies. Lucia has published numerous Italian and international articles and is very active in organizing events on a variety of related topics, including Serious Games, Gamification, VR, and enabling technologies throughout Europe. She has also been actively involved for some years on the boards of some regional groups dealing with eHealth and smart cities in Italy.

Prof. Zhen Yuan is a leading expert in neuroimaging and cognitive neuroscience, currently serving as a Professor at the Centre for Cognitive and Brain Sciences and the Faculty of Health Sciences at the University of Macau. He is also the Associate Director of the Institute of Collaborative Innovation. Prof. Yuan earned his Ph.D. in Engineering from the University of Science and Technology of China in 2001 and completed postdoctoral fellowships in bioengineering, physics, and biomedical engineering at the National University of Singapore, Clemson University, and the University of Florida, respectively. His academic career includes roles as Assistant and Associate Professor at the University of Macau, and prior to that, at Arizona State University and the University of Florida. From 2019 to 2023, he led the Centre for Cognitive and Brain Sciences at the University of Macau. Prof. Yuan's research focuses on neuroimaging, the brain connectome, and brain stimulation techniques including fNIRS, ultrasound stimulation, photomodulation, TMS, and tDCS. He has been recognized with numerous honors, including the 2016 Award for 10 Outstanding Research in Optics and the FHS Best Teacher Award in Research.

Dr. Manfred Doepp Born in Bad Berleburg/Germany. Medical studies in Munich and Giessen, exams and doctorate in 1971. Scientific assistant at the clinical centre of the Justus Liebig University at Giessen until 1978. Senior physician for nuclear medicine at the clinical centre in Hanau until 1985. Founder of the "International Institute for Experiential Medicine, Founder of the "Diagnostic Centre for Mineral Analysis and Spectroscopy DCMS. From 2011 to 2018 Head Physician of the Quantisana Health Centre for Holistic Diagnostics and Therapy in CH 9404 Rorschacherberg. Since 2018 Head of the HolisticCenter in CH 9030 Abtwil. Many oral and written publications in the field of complementary and energy medicine. Many videos on Youtube, Google and complementary portals. Reviewer of international journals. Co-founder and Deputy President of DGEIM.

Zhihao Xu, PhD candidate. Exchange researcher at the Warwick Medical School. I come from Wuhan, China, the Health Economic Centre of Wuhan University, with expertise in pharmacoeconomics, HTA, real-world study and drug & healthcare policy.

I am currently affiliated with Harbin Institute of Technology (Weihai), China. I hold a doctoral degree in Chemical Engineering and Technology from Harbin Institute of Technology. My research focuses on environmental toxicology, particularly the mechanisms of neurotoxicity induced by aquatic contaminants like cyanotoxins. With experience in zebrafish models and mitochondrial function analysis, she has conducted in-depth studies on L-BMAA’s neurotoxic effects, aiming to provide insights for neurodegenerative disease prevention and environmental risk assessment. Her interest in this field stems from a desire to address the intersection of environmental health and human well-being.

Anwesha Dutta is a dedicated neuroscience researcher with over eight years of experience in clinical and non-clinical studies, specializing in neuropsychiatric disorders. With a strong background in molecular biology, neuroimaging, and data analysis, she has contributed to groundbreaking research on bipolar disorder, psychosis, and Alzheimer's disease. Her work at Newcastle Magnetic Resonance Centre advanced lithium neuroimaging, while her epigenetic studies at King’s College London uncovered novel DNA methylation patterns linked to psychiatric conditions. As an R&D coordinator at AIzheimers UK, she integrates neuroimaging and AI for early dementia detection. Passionate about translational neuroscience, she actively bridges research and innovation to improve diagnostic and therapeutic strategies in neuropsychiatry

Alejandro Rao, a Colombian psychologist with a Master's degree in Biostatistics. My professional experience spans a decade, primarily focused on clinical and neuropsychological assessment, alongside the application of statistical methodologies for advancing epidemiology and public health within Colombia. Furthermore, I possess over five years of experience in teaching and research at highly regarded universities in the country. Rolan Correa Lopez is a psychologist specializing in clinical psychology and neuropsychology, with advanced doctoral studies in neurosciences and a background in philosophy. His extensive experience as an academic and researcher encompasses areas such as psychopathology, neurosciences, neuroanatomy, and clinical psychology. He has conducted significant research with pediatric populations affected by conduct disorders, dyslexia, and various neurodevelopmental pathologies. Dr. Correa Lopez is a lecturer at several prominent Colombian universities and an internationally recognized speaker, contributing to high-impact research journals.

A practicing physician in the field of healthcare in the state of Kerala in India for the last 37 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published Ten books on these subjects. I wrote hundreds of articles in various magazines. I have published 15 articles on fever in various journals. After scientific studies, we have developed 8000 affirmative cross checking questions. It can explain all queries related to fever.

Dr. Pritam Majumdar, Founder & Director of NuRaX Clinics, is a globally recognized leader in neuromodulation and neurosciences, celebrated for his clinical innovation and profound human impact. With expertise spanning Deep Brain Stimulation (DBS) for Parkinson’s, dystonia, and drug-resistant epilepsy; Spinal Cord Stimulation (SCS) for restoring function after spinal cord injuries; Epidural Stimulation to assist breathing and voluntary movement in paralyzed patients; and non-invasive neuromodulation therapies such as TMS and tDCS for pain, depression, and rehabilitation, he has transformed neurological care for thousands across more than 10 countries, including India, Brazil, Russia, Turkey, UAE, and Central Asia. His academic journey includes a PhD in Clinical Neurosciences from Germany, advanced fellowships in DBS, SCS, and epilepsy neuromodulation from the USA, and collaborations with leading institutions across the U.S., Europe, and Asia. As a clinician-scientist, Dr. Majumdar merges evidence-based medicine with personalized approaches, tackling complex neurorehabilitation cases such as disorders of consciousness, severe brain injuries, and rare neurological conditions. A passionate educator and innovator, he has trained physicians worldwide, led clinical trials, and contributed to global neuromodulation advancements as an active member of the International Neuromodulation Society, World Society for Stereotactic & Functional Neurosurgery, and International Epilepsy Society. Known for his precision, compassion, and patient-first philosophy, he pioneers programs that bring hope to underserved regions, launching advanced implant and rehabilitation services where they were once unavailable. Through NuRaX Clinics, his vision comes to life with state-of-the-art neuromodulation programs, specialized rehabilitation for spinal injuries, Parkinson’s, stroke, dystonia, and vegetative states, as well as international telemedicine and surgical collaborations. Where others see limits, Dr. Majumdar sees possibility—bringing relief where pain persists, restoring function where silence once dominated the nervous system, and championing next-generation neuroscience with empathy, expertise, and vision.

Shivi Kumar is a researcher, nonprofit founder, and aspiring physician-scientist dedicated to transforming the future of medicine through innovation, equity, and capital strategy. With a deep commitment to neuroscience, genomics, and global health, Shivi has made meaningful contributions to understanding complex medical issues such as metabolic hypoxia and brain tumors. Her research has been recognized by the American Academy of Neurology (AAN), where she was selected as a semifinalist for the Neuroscience Research Prize, and participated in the Regeneron Science Talent Search for her work on early-stage biomedical models. Currently, she is advancing her research at the intersection of synthetic biology, artificial intelligence, and precision oncology. She is also writing a slate of scientific papers that explore predictive genomics, neuroplasticity, and translational models of pediatric glioma. Equally passionate about finance and venture capital, Shivi is building a parallel track in biotech investment strategy, with a focus on healthcare M&A, synthetic biology valuation, and global biotech capital markets. She is currently preparing a whitepaper on FDA catalyst-driven trading models and has ongoing research in private equity roll-ups in healthcare services. Her long-term vision includes building a dual-career as a physician-investor, using capital as a tool to drive scalable, equitable innovation in underserved clinical fields. She intends to pursue roles in investment banking, healthcare private equity, or venture capital alongside academic medicine. Outside the lab and the market, Shivi is the founder of the Mind Matters Foundation, a youth-led nonprofit focused on pediatric neurodisparities and policy reform. She also co-founded STEM Beyond Borders, which provides education resources and research mentorship to displaced students and refugee youth worldwide. Her advocacy spans from grassroots mental health work to policy proposals aligned with the UN SDGs and WHO youth health equity goals. Above all, Shivi is driven by a vision to reshape how science, policy, and capital intersect to define healthcare innovation. With aspirations to lead global health efforts at the WHO, build next-gen biotech companies, and one day earn a Nobel Prize for her contributions to science and society, she is crafting a future in which medicine and markets work together to serve humanity.

Tanya Desai is a dynamic healthcare strategist with dual Master’s degrees in Clinical Neuroscience and Marketing & Analytics, uniquely positioned at the intersection of science, strategy, and storytelling. She supports the development of high-impact healthcare communications across therapeutic areas—including value propositions, provider education tools, payer engagement content, and scientific publications. In her previous work, Tanya has applied strategic storytelling to distill complex clinical and economic data into clear, compelling narratives tailored to diverse stakeholders. She has conducted competitive analysis and research to inform content strategies and has used design thinking to enhance clarity, engagement, and adoption in communication efforts. A published contributor to Forbes, Tanya writes on leadership, personal development, and inclusion in high-performance environments. At the upcoming Academy Nature Events Neuroscience Conference, she will present: “Driving Innovation in Neurodegeneration: Leveraging Scientific Storytelling and Strategic Communication to Accelerate Adoption.” Her session explores how effective communication—not just discovery—drives progress in CNS disorders by bridging innovation with understanding, trust, and real-world application. Tanya is passionate about transforming healthcare through evidence-based storytelling, equity-driven communication models, and forward-thinking strategies that connect research to meaningful impact.

Florent Pirot is a multidisciplinary researcher with Einstein Syndrome and specialties in geophysics, nuclear physics, astrophysics as well as biology and health. He got his graduate in economics and political sciences (Sciences Po Lille, College of Europe and CAPES in economics and sociology).

I hold a Master’s degree in neuroscience from King’s College London, where I have specialized in molecular neurobiology and neurodegenerative disease research. My work includes CRISPR-Cas9 genome editing, zebrafish behavioral models, RT-PCR, and confocal microscopy, with a focus on conditions such as ALS, Alzheimer’s, and Duchenne muscular dystrophy. I have been part of collaborative research projects across India, the UK, and the US, and I am passionate about advancing translational neuroscience.

Epilepsy is a neurological disorder characterized by recurrent seizures, which can affect individuals’ daily lives significantly. Understanding the public’s knowledge, attitudes, and practices (KAP) towards epilepsy is crucial for effective health education and management strategies. This study aimed to assess the perception, attitude and practice among a rural population in Sudan towards epilepsy. Method and Materials: This study was a descriptive cross-sectional, community-based study conducted in March 2023 at a rural area in Gezira state in the central part of Sudan. A self-constructed questionnaire was designed by authors based on revision of previous similar studies. It consisted of four domains: The first domain was about sociodemographic data (age, gender, occupation, residence and educational level). The second, third and fourth domains consisted of questions regarding knowledge, attitude and practice. 150 participants were involved in this study and data was analysed by SPSS version 22. Results: The total number of participant in this study was 150 individuals. The majority (83) were females (55.3%) and 36% of respondents were in the age group (15-30). The overall net result of KAP of the participants in this study towards epilepsy was as follows: for knowledge it was 67.9%, attitude 63.5% and practice 53.9%. There was no significant association between gender and knowledge of epilepsy, P-value 0.887. Conclusion: The current study’s findings underscore the need for targeted educational interventions to dispel myths and misconceptions about epilepsy. Increasing awareness through community-based programs can help reduce the stigma and improve the quality of life for epileptic individuals. Comparative analysis with other studies highlights the universal challenge of epilepsy-related stigma and the critical role of education in mitigating its impact.

Dr. Mohamed Nadeem has been done Bachelor degree in Medicine University of Science & Technology Yemen. Internal Medicine Egyptian Fellowship.